Alzheimer’s disease serves as bookends to Brent Vaughan’s career so far. Twenty years ago, he worked for a Bay Area biotech whose pipeline included small molecules in development for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback